Civetta Therapeutics is a privately held biotechnology company focused on the discovery and development of a new class of medicines that target beta-propeller (β-propeller) proteins. These proteins are involved in a wide array of cellular processes, and their dysregulation is implicated in numerous diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. Civetta's proprietary platform leverages deep biological insights and advanced chemical biology to unlock the therapeutic potential of this largely unexploited protein class, aiming to deliver transformative therapies for patients with serious unmet medical needs.
Serves as the central hub for research and development, corporate strategy, business development, and administrative operations.
Located within Technology Square, known for its concentration of life science and technology companies, offering access to state-of-the-art laboratory and office facilities.
Likely a dynamic, science-driven, and collaborative environment typical of early to mid-stage biotech companies, emphasizing innovation, scientific rigor, and a patient-centric mission.
Proximity to world-class academic institutions (MIT, Harvard), research hospitals, venture capital, and a rich talent pool of scientists and biotech professionals, fostering collaboration and innovation.
Civetta Therapeutics currently operates primarily from its headquarters in Cambridge, MA, USA. Its global strategy may involve future collaborations, clinical trial sites, or partnerships as its therapeutic programs advance. As a company focused on addressing global unmet medical needs, its research and development efforts have international implications.
400 Technology Square, Suite 200
Cambridge
MA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Civetta Therapeutics' leadership includes:
Civetta Therapeutics has been backed by several prominent investors over the years, including:
No major publicly announced executive hires or departures have been noted for Civetta Therapeutics in the last 12 months. The leadership team appears to be stable based on available information.
Discover the tools Civetta Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Common email formats for Civetta Therapeutics likely follow standard corporate patterns. The most probable format is [first_initial][last]@civettatherapeutics.com.
[first_initial][last]@civettatherapeutics.com
Format
cwestphal@civettatherapeutics.com
Example
80%
Success rate
Fierce Biotech • October 2, 2019
Civetta Therapeutics officially launched with a $53 million Series A financing. The round was co-led by Deerfield Management and Longwood Fund, with participation from Omega Funds. The company aims to develop a new class of medicines by targeting beta-propeller proteins....more
PR Newswire • January 5, 2022
Civetta Therapeutics announced the appointment of Jesse Chen, Ph.D., as Chief Business Officer. Dr. Chen brings extensive experience in business development and strategy in the biopharmaceutical industry to Civetta....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Civetta Therapeutics, are just a search away.